Possible Effects on Addiction and Reward Pathways Researchers are actively studying GLP-1 medications for their possible role in reducing: Alcohol cravings Nicotine cravings Compulsive shopping Gambling urges Other dopamine-driven behaviors Some patients report reduced interest in alcohol or other compulsive behaviors while on treatment
Semaglutide reduces vascular inflammation investigated by PET in a rabbit model of advanced atherosclerosis and inflammatory marker high-sensitivity C-reactive protein (hsCRP) und stimulates browning of adippose tissue
Key warning signs include sudden severe right upper abdominal pain (especially after fatty meals), fever, jaundice, dark urine, pale stools, and persistent nausea or vomiting
Our region also carries one of the highest burdens of cardiovascular disease, type 2 diabetes, and related conditions in the South
Use SingleCares search bar to find the specific drug and see the discounted costs available at your nearby pharmacies